Patent 7128893 was granted and assigned to Endocyte on October, 2006 by the United States Patent and Trademark Office.
The invention relates to compounds and methods for targeting radionuclide-based imaging agents to cells having receptors for a vitamin, or vitamin receptor binding derivative or analog thereof, by using such a vitamin as the targeting ligand for the imaging agent. The invention provides a compound of the formula